175 related articles for article (PubMed ID: 32508750)
21. Evidence That Graves' Ophthalmopathy Immunoglobulins Do Not Directly Activate IGF-1 Receptors.
Marcus-Samuels B; Krieger CC; Boutin A; Kahaly GJ; Neumann S; Gershengorn MC
Thyroid; 2018 May; 28(5):650-655. PubMed ID: 29631510
[TBL] [Abstract][Full Text] [Related]
22. TSH/IGF1 receptor crosstalk: Mechanism and clinical implications.
Krieger CC; Neumann S; Gershengorn MC
Pharmacol Ther; 2020 May; 209():107502. PubMed ID: 32061922
[TBL] [Abstract][Full Text] [Related]
23. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
24. GRK2 and beta-arrestin 1 as negative regulators of thyrotropin receptor-stimulated response.
Iacovelli L; Franchetti R; Masini M; De Blasi A
Mol Endocrinol; 1996 Sep; 10(9):1138-46. PubMed ID: 8885248
[TBL] [Abstract][Full Text] [Related]
25. Studies on homologous desensitization of the thyrotropin receptor in 293 human embryonal kidney cells.
Nagayama Y; Chazenbalk GD; Takeshita A; Kimura H; Ashizawa K; Yokoyama N; Rapoport B; Nagataki S
Endocrinology; 1994 Sep; 135(3):1060-5. PubMed ID: 8070347
[TBL] [Abstract][Full Text] [Related]
26. TSH/IGF-1 Receptor Cross-Talk Rapidly Activates Extracellular Signal-Regulated Kinases in Multiple Cell Types.
Krieger CC; Perry JD; Morgan SJ; Kahaly GJ; Gershengorn MC
Endocrinology; 2017 Oct; 158(10):3676-3683. PubMed ID: 28938449
[TBL] [Abstract][Full Text] [Related]
27. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.
Chipoy C; Berreur M; Couillaud S; Pradal G; Vallette F; Colombeix C; Rédini F; Heymann D; Blanchard F
J Bone Miner Res; 2004 Nov; 19(11):1850-61. PubMed ID: 15476586
[TBL] [Abstract][Full Text] [Related]
29. [Peptide 612-627 of thyrotropin receptor and its modified derivatives as the regulators of adenylyl cyclase in the rat thyroid gland].
Shpakov AO; Shpakova EA; Tarasenko II; Derkach KV
Tsitologiia; 2014; 56(7):526-35. PubMed ID: 25696997
[TBL] [Abstract][Full Text] [Related]
30. Thyrotropin Receptor: Allosteric Modulators Illuminate Intramolecular Signaling Mechanisms at the Interface of Ecto- and Transmembrane Domain.
Marcinkowski P; Kreuchwig A; Mendieta S; Hoyer I; Witte F; Furkert J; Rutz C; Lentz D; Krause G; Schülein R
Mol Pharmacol; 2019 Oct; 96(4):452-462. PubMed ID: 31399504
[TBL] [Abstract][Full Text] [Related]
31. Cloning of the single strand DNA-binding protein important for maximal expression and thyrotropin (TSH)-induced negative regulation of the TSH receptor.
Ohmori M; Ohta M; Shimura H; Shimurat Y; Suzuki K; Kohn LD
Mol Endocrinol; 1996 Nov; 10(11):1407-24. PubMed ID: 8923467
[TBL] [Abstract][Full Text] [Related]
32. The Molecular Function and Clinical Role of Thyroid Stimulating Hormone Receptor in Cancer Cells.
Chu YD; Yeh CT
Cells; 2020 Jul; 9(7):. PubMed ID: 32698392
[TBL] [Abstract][Full Text] [Related]
33. RGS 2 expression is regulated by TSH and inhibits TSH receptor signaling.
Eszlinger M; Holzapfel HP; Voigt C; Arkenau C; Paschke R
Eur J Endocrinol; 2004 Sep; 151(3):383-90. PubMed ID: 15362969
[TBL] [Abstract][Full Text] [Related]
34. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland.
Suh JM; Song JH; Kim DW; Kim H; Chung HK; Hwang JH; Kim JM; Hwang ES; Chung J; Han JH; Cho BY; Ro HK; Shong M
J Biol Chem; 2003 Jun; 278(24):21960-71. PubMed ID: 12668683
[TBL] [Abstract][Full Text] [Related]
35. High affinity binding of thyrotropin (TSH) and thyroid-stimulating autoantibody for the TSH receptor extracellular domain.
Nagayama Y; Takeshita A; Luo W; Ashizawa K; Yokoyama N; Nagataki S
Thyroid; 1994; 4(2):155-9. PubMed ID: 7919997
[TBL] [Abstract][Full Text] [Related]
36. TSH inhibits eNOS expression in HMEC-1 cells through the TSHR/PI3K/AKT signaling pathway.
Chen J; Shi M; Wang N; Yi P; Sun L; Meng Q
Ann Endocrinol (Paris); 2019 Nov; 80(5-6):273-279. PubMed ID: 31606200
[TBL] [Abstract][Full Text] [Related]
37. Expression of cell growth and bone phenotypic genes during the cell cycle of normal diploid osteoblasts and osteosarcoma cells.
McCabe LR; Last TJ; Lynch M; Lian J; Stein J; Stein G
J Cell Biochem; 1994 Oct; 56(2):274-82. PubMed ID: 7829587
[TBL] [Abstract][Full Text] [Related]
38. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
[TBL] [Abstract][Full Text] [Related]
39. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity.
Sanders J; Evans M; Betterle C; Sanders P; Bhardwaja A; Young S; Roberts E; Wilmot J; Richards T; Kiddie A; Small K; Platt H; Summerhayes S; Harris R; Reeve M; Coco G; Zanchetta R; Chen S; Furmaniak J; Smith BR
Thyroid; 2008 Jul; 18(7):735-46. PubMed ID: 18631002
[TBL] [Abstract][Full Text] [Related]
40. Suppression of thyrotropin receptor-G protein-phospholipase C coupling by activation of protein kinase C in thyroid carcinoma cells.
Broecker M; Mayr GW; Derwahl M
Endocrinology; 1997 Sep; 138(9):3787-96. PubMed ID: 9275066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]